I agree with you that for long tern growth and sustainability they need a pipeline and if EORTC fails to show any survivial benifit they'll really need one.
BUT the point I was trying to make was the stock was 7 bucks and change without any credit for the pipeline and to get back there in a hurry we need decent EORTC results. Im selfish I want to see a quick pop instead of this dearh by a thousands cuts.
Any stock appreciation if ever that can be attached to the pipeline is 18 months away minimum IMHO
I agree with both of you. We need Dacogen with some news and additional approvals and we need the pipeline in the background showing some validation. Long term Dacogen may get us to 10.00 a share and longer term Pipeline needed to show additional revenue sources. It's all needed and necessary for investors to take notice and hopefully some big pharma to scoup it all up.